» Articles » PMID: 81635

Levamisole and Inosiplex: Antiviral Agents with Immunopotentiating Action

Overview
Specialty Science
Date 1977 Mar 4
PMID 81635
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (M).

Khatabi K, Aanouz I, Alaqarbeh M, Ajana M, Lakhlifi T, Bouachrine M Bioimpacts. 2022; 12(2):107-113.

PMID: 35411302 PMC: 8905587. DOI: 10.34172/bi.2021.22143.


Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS).

Tsang P, Tangnavarad K, Solomon S, BEKESI J J Clin Immunol. 1984; 4(6):469-78.

PMID: 6210301 DOI: 10.1007/BF00916577.


Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.

Ohnishi H, Kosuzume H, Inaba H, Okura M, Morita Y, Mochizuki H Infect Immun. 1982; 38(1):243-50.

PMID: 6183209 PMC: 347725. DOI: 10.1128/iai.38.1.243-250.1982.


Effect of immunomodulating agents on leucocyte chemotaxis and cyclic nucleotides.

Roch-Arveiller M, Tissot M, Moachon L, Giroud J Agents Actions. 1982; 12(3):353-9.

PMID: 6182777 DOI: 10.1007/BF01965403.


Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Sorkin E, Heel R Drugs. 1986; 32(5):383-424.

PMID: 2431857 DOI: 10.2165/00003495-198632050-00001.